Published on
October 20, 2022
- 19:00 GMT
Maxwell Biomedical Completes First-in-Human Study Enrollment and Testing of Spatial Resynchronization™ Therapy
Spatial Resynchronization Therapy (SR™T) demonstrates proof-of-concept in repeatedly terminating atrial fibrillation (AFib) and restoring sinus rhythm SAN DIEGO, CALIFORNIA, UNITED STATES, October 20, 2022 /EINPresswire.com/ -- Maxwell Biomedical …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
